{
    "2021-06-07": [
        [
            {
                "time": "",
                "original_text": "海博特完成Pre-B轮融资｜泰格医药领投，推动真研、助力研发",
                "features": {
                    "keywords": [
                        "海博特",
                        "Pre-B轮融资",
                        "泰格医药",
                        "研发"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：如何从大品种价值理解前沿生物？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "大品种价值",
                        "前沿生物"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药与健康护理行业周报：广东地区疫情反复 核酸检测需求大增",
                "features": {
                    "keywords": [
                        "医药",
                        "健康护理",
                        "疫情反复",
                        "核酸检测",
                        "广东"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "健康护理"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药：股东曹晓春质押250万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "股东",
                        "曹晓春",
                        "质押",
                        "250万股"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：新冠疫苗标的调整到位 重点推荐智飞生物、复星医药等",
                "features": {
                    "keywords": [
                        "医药生物",
                        "新冠疫苗",
                        "智飞生物",
                        "复星医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业行业周报：继续看好CXO行业 头部公司仍有成长空间",
                "features": {
                    "keywords": [
                        "医药行业",
                        "CXO行业",
                        "头部公司",
                        "成长空间"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}